Yohimbe

Yohimbe bark's primary active compound is yohimbine, a selective alpha-2 adrenergic receptor antagonist. By blocking these receptors, yohimbine increases sympathetic nervous system activity, raising noradrenergic tone, heart rate, and blood pressure. It also affects penile vasculature, contributing to historical use for erectile dysfunction. Unlike pharmaceutical yohimbine, yohimbe bark contains a complex mixture of alkaloids (including corynanthine, alpha-yohimbine, and others) plus tannins and other plant compounds. The total yohimbine content varies widely between yohimbe bark products, with the FDA noting that many commercial products contain very different amounts than declared on labels. Some products have been found to contain almost no yohimbine, while others contain dangerously high amounts. For fat loss applications, yohimbe bark is marketed for similar reasons as pure yohimbine (alpha-2 antagonism promoting lipolysis from stubborn fat deposits), but the variable yohimbine content makes effects unpredictable. The combination of multiple alkaloids may also produce additive or unexpected effects.

There is no established RDA. Traditional yohimbe bark preparations have used variable amounts of dried bark. Modern supplements typically contain 50 to 500 mg of bark extract per dose, sometimes standardized to a percentage of total alkaloids. Due to highly variable yohimbine content in commercial products, accurate dose-response is difficult to predict. Start with lower doses to assess tolerance.

Yohimbe is typically taken on an empty stomach for maximum absorption. Doses are commonly divided through the day, but avoid taking after 4 PM due to potential sleep disturbance. Start with a low dose and assess tolerance before increasing. The variable potency of yohimbe products makes precise timing recommendations difficult; consider waiting at least 6 hours between doses.

Yohimbe bark products have been linked to many adverse event reports. Common side effects include anxiety, jitteriness, elevated heart rate and blood pressure, palpitations, headache, sweating, dizziness, nausea, and insomnia. Serious effects, more likely at high or unintentionally high doses, include severe hypertension, cardiac arrhythmias, panic attacks, seizures, and rare cases of kidney failure. FDA has flagged yohimbe products for inconsistent labeling and adverse events. There is no established Tolerable Upper Intake Level.

Yohimbe shares yohimbine's interaction profile. Significant interactions include MAO inhibitors (hypertensive crisis risk), stimulants including caffeine and amphetamines, antidepressants (especially tricyclics and SSRIs), antihypertensives, alpha-2 agonists like clonidine, and diabetes medications. The variable composition of yohimbe bark may increase unpredictability of interactions.